ABSTRACT
Objectives Horizon-scanning for innovative technologies that might be applied to medical products and require new assessment approaches/regulations will help to prepare regulators, allowing earlier access to the product for patients and an improved benefit/risk ratio. In this study, we focused on the field of AI-based medical image analysis as a retrospective example of medical devices, where many products have recently been developed and applied. We proposed and validated horizon-scanning using citation network analysis and text mining for bibliographic information analysis.
Methods and analysis Research papers for citation network analysis which contain “convolutional*” OR “machine-learning” OR “deep-learning” were obtained from Science Citation Index Expanded (SCI-expanded) in the Web of Science (WoS). The citation network among those papers was converted into an unweighted network with papers as nodes and citation relationships as links. The network was then divided into clusters using the topological clustering method and the characteristics of each cluster were confirmed by extracting a summary of frequently cited academic papers, and the characteristic keywords, in the cluster.
Results We classified 119,553 publications obtained from SCI and grouped them into 36 clusters. Hence, it was possible to understand the academic landscape of AI applications. The key articles on AI-based medical image analysis were included in one or two clusters, suggesting that clusters specific to the technology were appropriately formed. Based on the average publication year of the constituent papers of each cluster, we tracked recent research trends. It was also suggested that significant research progress would be detected as a quick increase in constituent papers and the number of citations of hub papers in the cluster.
Conclusion We validated that citation network analysis applies to the horizon-scanning of innovative medical devices and demonstrated that AI-based electrocardiograms and electroencephalograms can lead to the development of innovative products.
Strengths and limitations of this study
Citation network analysis can provide an academic landscape in the investigated research field, based on the citation relationship of research papers and objective information, such as characteristic keywords and publication year.
It might be possible to detect possible significant research progress and the emergence of new research areas through analysis every several months.
It is important to confirm the opinions of experts in this area when evaluating the results of the analysis.
Information on patents and clinical trials for this analysis is currently unavailable.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by AMED (Japan Agency for Medical Research and Development) under Grant Number JP20mk0101155.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the corresponding author, Mayumi Shikano, upon reasonable request.
